CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Option exercise Director acquired 1 shares (option exercise)
- 4 Option exercise Director acquired 1 shares (option exercise)
- 4 Option exercise Director acquired 1 shares (option exercise)
- 4 Option exercise Director acquired 1 shares (option exercise)
- 4 Option exercise Director acquired 1 shares (option exercise)
- 4 Option exercise SVP, CFO acquired 3 shares (option exercise)
- 4 Option exercise SVP, GC, BD & Corp Affairs acquired 3 shares (option exercise)
- 4 Option exercise President and CEO acquired 10 shares (option exercise)
- 4 Option exercise EVP, COO acquired 5 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 8-K Event Other events
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 6 of 38 · 742 filings